Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis

South Africa led the world with guidelines on bedaquiline (BDQ) use as a single drug substitution to manage rifampin resistant tuberculosis regimen toxicity. We examined reasons for giving BDQ in a retrospective cohort: >75% of patients were switched to BDQ for toxicity (ototoxicity or renal dysf...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouton, Tara C., de Vos, Margaretha, Ragan, Elizabeth J., White, Laura F., Van Zyl, Leonie, Theron, Danie, Horsburgh, C. Robert, Warren, Robin M., Jacobson, Karen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797261/
https://www.ncbi.nlm.nih.gov/pubmed/31622366
http://dx.doi.org/10.1371/journal.pone.0223308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797261/
https://www.ncbi.nlm.nih.gov/pubmed/31622366
http://dx.doi.org/10.1371/journal.pone.0223308

Ejemplares similares